Last reviewed · How we verify
Avibactam sodium/Ceftazidime hydrate — Competitive Intelligence Brief
preclinical
Live · refreshed every 30 min
Target snapshot
Avibactam sodium/Ceftazidime hydrate (avibactam-sodium-ceftazidime-hydrate) — Pfizer Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Avibactam sodium/Ceftazidime hydrate TARGET | avibactam-sodium-ceftazidime-hydrate | Pfizer Inc. | preclinical |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Avibactam sodium/Ceftazidime hydrate CI watch — RSS
- Avibactam sodium/Ceftazidime hydrate CI watch — Atom
- Avibactam sodium/Ceftazidime hydrate CI watch — JSON
- Avibactam sodium/Ceftazidime hydrate alone — RSS
Cite this brief
Drug Landscape (2026). Avibactam sodium/Ceftazidime hydrate — Competitive Intelligence Brief. https://druglandscape.com/ci/avibactam-sodium-ceftazidime-hydrate. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab